Recently, we could show that the focal adhesion protein leupaxin (LPXN) is expressed in human prostate carcinomas (PCa) and induces invasiveness of androgenindependent PCa cells. In this study we show that LPXN enhanced the progression of existing PCa in vivo by breeding transgenic mice with prostate-specific LPXN expression and TRAMP mice (transgenic adenocarcinoma of mouse prostate). Double transgenic LPXN/ TRAMP mice showed a significant increase in poorly differentiated PCa and distant metastases as compared with control TRAMP mice. Additional studies on primary PCa cells generated from both transgenic backgrounds confirmed the connection regarding LPXN overexpression and increased motility and invasiveness of PCa cells. One mediator of LPXN-induced invasion was found to be the cell-cell adhesion protein p120catenin (p120CTN). Both in vitro and in vivo experiments revealed that p120CTN expression negatively correlates with LPXN expression, followed by a redistribution of b-catenin. Downregulation of LPXN using small interfering RNAs (siRNAs) resulted in a membranous localization of b-catenin, whereas strong nuclear accumulation of b-catenin was observed in p120CTN knockdown cells leading to enhanced transcription of the b-catenin target gene matrix metalloprotease-7. In conclusion, the present results indicate that LPXN enhances the progression of PCa through downregulation of p120CTN expression and that LPXN could function as a marker for aggressive PCa in the future.
Introduction
Prostate cancer is the second most common cause of cancer death among men in developed countries (Greenlee et al., 2001) . A number of early-stage tumours exhibit a slow growth rate and are not life threatening. Many men are appropriately concerned about the impact of prostate cancer treatment on sexual and urinary function. Therefore, watchful waiting in terms of delaying therapy in favour of careful surveillance is an attractive concept for men with localized prostate carcinoma (PCa). However, a subset of PCa will progress to give rise to metastasis and cancer-related death. Treatment strategies, for example, hormonal therapy and chemotherapy (Millikan et al., 2008) , clearly show a survival benefit, but never a cure. Although a number of genetic and epigenetic changes have been documented in advanced PCa, cellular mechanisms involved in the progression of localized PCa to metastasis remain unknown. Therefore, it is absolutely necessary to identify pathways and their components contributing to PCa progression and to search for potential progression markers for therapeutic interventions of advanced and aggressive PCa.
The invasive process in cancer represents a combination of complex genetic events that lead initially to changes in adhesive properties, allowing transformed cells to escape from the primary site, breaking down connective barriers, gaining access to the circulation and forming metastatic colonies (Lauffenburger and Horwitz, 1996; Rowe and Weiss, 2008) . Thus, the two most important attributes of invasive tumour cells are the disruption of the extracellular matrix and the interaction with the microenvironment. For epithelial tumours in an incipient state, the basement membrane acts as a barrier against the invasion of transformed cells into the subjacent stroma. The proteolytically disruption of the basement membrane is catalysed by matrix metalloproteases (MMPs), which are present at proteolytic structures such as lamelipodia, invadopodia and podosomes, and mediate the degradation of the extracellular matrix (Gupta and Massague´, 2006; Bidard et al., 2008; Gimona et al., 2008) . A positive correlation between tumour progression and the expression of multiple MMP family members in tumour tissues has been shown in numerous human studies (Ellerbroek and Stack, 1999; Stetler-Stevenson, 2001 ).
The interaction between the tumour cell and the microenvironment is another essential step in the process of metastasis, and is mediated through integrins and growth factors. Intervention of the integrins with the extracellular matrix results in the formation of protein complexes termed focal adhesions, which perform a platform for integrin and growth factorinduced pathways and enable communication between the microenvironment and the cell (Wegener and Campbell, 2008) .
One group of proteins, which are localized at focal adhesion sites, are members of the paxillin protein family. In addition to the eponymous paxillin, the androgen receptor-associated protein 55 kDa (ARA55) and leupaxin (LPXN) belong to the paxillin superfamily (Brown and Turner, 2004) . All members of the paxillin family are characterized by the presence of two protein-protein interaction domains, namely LD motifs and LIM domains (Lipsky et al., 1998) . By means of this protein structure they can attach to the cytoplasmic domain of integrins and transmit signals from the outside of the cell. Furthermore, it was already described that paxillin family members shuttle to the nucleus, activate and interact with different steroid hormone receptors and transcription factors regulating the expression of target genes in response to outer signals (Fujimoto et al., 1999; Kasai et al., 2003; Shibanuma et al., 2003 Shibanuma et al., , 2004 Wang et al., 2005 Wang et al., , 2008 .
Leupaxin was originally characterized as a multifunctional adaptor protein, which is preferentially expressed in hematopoietic cells (Lipsky et al., 1998) . In murine osteoclasts, FAK, PTP-PEST and p95PKL (paxillin kinase linker) could be identified as interaction partners of LPXN (Gupta et al., 2003) . Recently, we identified LPXN as a protein, which is overexpressed in a subset of human prostate cancer specimens and a positive correlation between enhanced LPXN expression and tumour stage was depicted. In addition, the influence of LPXN expression on invasion and migration of human PCa cells was shown in vitro using RNA interference studies. Moreover, we could show that LPXN functioned as a coactivator of the androgen receptor (Kaulfuss et al., 2008) .
To date, it was not proven for any of the paxillin family members that a direct connection exists between their expression levels and PCa development and progression. In this study, we could show for the first time that LPXN acts directly as a mediator of prostate cancer cell progression in vitro and in vivo. Furthermore, we could show that LPXN influences the expression of p120CTN, the subcellular localization of b-catenin and regulates the expression of MMP-7, which is known to be involved in invasion of carcinoma cells. Taken together, our present data indicate that LPXN could function as a putative target for therapeutic interventions for progressive PCa.
Results

Generation of transgenic mice expressing LPXN in prostate epithelium
In a previous report we have characterized LPXN as a protein, which is expressed in a subset of human PCa (Kaulfuss et al., 2008) . To analyse the role of LPXN in PCa in vivo, we generated transgenic mice with prostatespecific overexpression of LPXN ( Supplementary  Figures 1 and 2) . To confirm the functionality of the transgene construct before integration, human androgen-dependent LNCaP cells were transiently transfected with the rPB-hLPXN-cmyc plasmid and checked by using western blot analysis, immunocytochemistry and a transactivation assay as described previously (Supplementary Figure 1a-c; Kaulfuss et al., 2008) . Independent LPXN mouse lines from two founders on a FVB background were analysed in detail (nos. 19 and 20) . The transgenic protein tLPXN-cmyc was only detectable in prostate tissue, but not in other tissues using western blot analysis and immunohistochemical staining ( Supplementary Figures 1d and 2a) . Histopathological examinations revealed no obvious abnormalities in the prostate glands of LPXN transgenic mice up to the age of 18 months (Supplementary Figure 2b) .
LPXN promotes prostate cancer progression in a murine model of prostate cancer To analyse the influence of LPXN regarding the progression of established PCa in vivo, we generated double heterozygous transgenic LPXN/TRAMP mice. TRAMP mice (transgenic adenocarcinoma of mouse prostate) carry the SV40 T/t antigen under the rat minimal probasin promoter and form an autochthonous model for prostate cancer in the C57Bl/6 inbred mouse strain (Greenberg et al., 1995) . TRAMP mice were crossed with both LPXN mouse lines (nos. 19 and 20) . Only the F1 generation of double transgenic LPXN/ TRAMP and as a control of single transgenic LPXN and TRAMP males were analysed at the age of 6, 10, 14, 18, 22, 26 and 30 weeks. Transgenic tLPXN-cmyc expression was detected in prostates of LPXN/TRAMP (L/-T/-) mice, but not in TRAMP (T/-) control mice ( Figure 1a) . It is important to note that murine LPXN was not expressed in normal or tumour tissue of TRAMP prostates indicating that LPXN was not involved in the transformation of cells by SV40 T/t antigen ( Figure 1a , lower panel).
Gross examination of prostate glands and other male accessory organs revealed a marked increase in tumour burden in LPXN/TRAMP mice in comparison with single transgenic TRAMP mice. The ratio of genitourinary tract versus mouse body weight was calculated and the logarithmic trendline shows that the tumour growth in both LPXN/TRAMP mouse lines is significantly higher as compared with TRAMP control mice (Figure 1b) .
Histological examination of haematoxylin-eosin sections of prostate tissues was used to evaluate the consequence of LPXN overexpression in the LPXN/ TRAMP mouse (see Materials and methods section). Between 18 and 26 weeks of age the majority of LPXN/ TRAMP mice already developed poorly differentiated carcinoma, whereas prostate intraepithelial neoplasia was the most frequent phenotype of the prostate in TRAMP control mice at these time points (Figure 1c ). For example, at the age of 22 weeks, 93% of double transgenic LPXN/TRAMP mice displayed poorly differentiated carcinoma, whereas TRAMP mice at the same age showed morphological changes of the tissue in terms of prostate intraepithelial neoplasia (86%; Figure 2a , b). However, the onset of the prostatic lesions of LPXN/TRAMP and control mice was not altered. To evaluate the development of metastases in different organs, we also dissected and histopathologically analysed the lymph nodes, lung, liver, spleen and kidney. Metastases were more common in LPXN/ TRAMP mice than in TRAMP control mice (Figure 2a, c) . Taken together, these results point towards a direct connection between LPXN expression and the progression of PCa in double transgenic LPXN/ TRAMP mice.
LPXN promotes migratory and invasive behaviour of murine primary PCa cells For functional analysis of LPXN, we established culture conditions of murine primary PCa cells of both transgenic mouse strains (LPXN/TRAMP and TRAMP). The purity of the different cell lines was analysed by immunostaining with the SV40 antibody ( Figure 3a) . In addition, expression of SV40T antigen and tLPXN-cmyc was verified by western blotting (Figure 3b ). To determine the behaviour of LPXN/ TRAMP (cell clones 72A and 83A) and TRAMP (cell clones 27F and 45F) PCa cells in migration and invasion, we performed a wound healing assay and an in vitro matrigel invasion assay. As shown in Figure 3c threefold increased migratory ability as compared with control cells after 24 h of incubation. Furthermore, the invasive behaviour of LPXN/TRAMP PCa cells was significantly higher than in TRAMP PCa cells ( Figure 3d ). These data confirm that the findings observed in the murine model can be attributed to the function of LPXN.
The expression of the adhesion molecule p120CTN is negatively correlated with the expression of LPXN It is already known that downregulation of LPXN expression using RNA interference in PC-3 and DU 145 cells induces a significant decrease in invasive capacity and motility (Kaulfuss et al., 2008) . To identify genes, which are responsible for the effects observed after the downregulation of LPXN expression in PCa cells, adhesion-specific cDNA array analysis was performed. After densitometric evaluation of the arrays, the cell-cell adhesion molecule p120catenin (p120CTN) was found to be upregulated after downregulation of LPXN expression (data not shown). The p120CTN protein is part of a multiprotein cell-cell adhesion complex (Peifer et al., 1994; Reynolds et al., 1994) , and its expression is downregulated in approximately 50% of human prostate adenocarcinomas (Kallakury et al., 2001a, b) . Quantitative real-time-PCR and western blot analyses clearly confirmed increased p120CTN expression in LPXN small interfering RNAs (siRNA)-transfected cells as compared with luciferase siRNA-transfected control cells (Figure 4a, b) . To further confirm these results, the TAT-mediated protein transduction system was used to mimic overexpression of LPXN in human PCa cells (Becker-Hapak et al., 2001 ; see Materials and methods section). As can be seen in Figure 5a , the fusion protein TAT-LPXN-EGFP (TAT-LPXN) could be detected by western blotting using an LPXN-specific antibody. A threefold (PC-3) and twofold (DU 145) increased invasiveness ( Figure 5b ) and an increased migratory capability (data not shown) of PCa cells was observed after transduction with TAT-LPXN as compared with TAT-EGFP-transduced control cells. These
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T/- To elucidate the involvement of p120CTN in the LPXN/TRAMP mouse model as well, total proteins from normal prostates and from PCa of LPXN/ TRAMP and TRAMP mice were analysed by using western blot analysis. A specific downregulation of p120CTN expression in poorly differentiated carcinoma in comparison with normal prostate tissue was observed in both mouse strains (Figure 6a, b) . More important, the expression of p120CTN in normal prostate and PCa of double transgenic LPXN/TRAMP mice was even more reduced due to the overexpression of LPXN than in normal prostate and PCa of single transgenic TRAMP mice (Figure 6b, c) . Similar results were also obtained in the primary PCa cell lines from LPXN/TRAMP and TRAMP control mice (Figure 3b) . Therefore, these results provide strong evidence for a regulation of p120CTN expression in response to LPXN expression.
T-L/-T/-
Knockdown of p120CTN in PC-3 PCa cells results in increased invasiveness and migratory behaviour Does p120CTN represent a mediator of LPXN-induced progressive behaviour of PCa cells? To address this issue, expression levels of both proteins were downregulated using RNA interference (Figure 7a ). Wound healing and matrigel invasion assays showed highly elevated migratory capabilities and a 34% increased invasiveness of PC-3 cells after knockdown of p120CTN alone (Figure 7b, c) . When both, p120CTN and LPXN, were knocked down simultaneously in PC-3 cells, a reversion of the effects of downregulated LPXN expression could be observed. Together with previous expression studies (Kallakury et al., 2001a, b; van Oort et al., 2007) , our findings indicate that loss of p120CTN is capable of facilitating the progression of PCa and that p120CTN represents a mediator of LPXN-induced invasiveness and migration. 
Downregulation of LPXN enhances the expression of the b-catenin target gene MMP-7
Accumulation of b-catenin in the nucleus results in transcription of different target genes, for example, the matrix metalloproteinase-7 (MMP-7). MMP-7 has important roles in the degradation of the extracellular matrix (Ii et al., 2006) , and high levels of MMP-7 expression have been associated with a poor prognosis in different cancers (McDonnell et al., 1991; Shiomi and Okada, 2003; Jones et al., 2004) . Therefore, we examined the expression of MMP-7 after downregulation of LPXN and p120CTN expression in PC-3 cells using quantitative real-time-PCR. Knockdown of LPXN reduced the expression of MMP-7 to 45% of control levels, whereas knockdown of p120CTN resulted in a fourfold elevated expression of MMP-7. Knockdown of both LPXN and p120CTN reversed these effects, resulting in a normal MMP-7 expression level ( Figure 8c ). In addition, the expression of MMP-7 was upregulated after overexpression of different LPXN fusion proteins (Figure 8d ). In contrast, the expression level of another b-catenin target gene connected with proliferation, that is, cycline D1 was not changed in response to LPXN and p120CTN knockdown in PCa cells (data not shown).
Discussion
Recently, the focal adhesion molecule LPXN was identified as a protein, which is differentially expressed in human PCa (Kaulfuss et al., 2008) . In that study the influence of LPXN in vitro on migration and invasion of PCa cells was shown. However, the proof for a direct involvement of LPXN in the initiation and progression of PCa cells in vivo was still lacking. This issue was investigated in the present report by generating transgenic mice with a prostate-specific overexpression of LPXN. These LPXN mice showed no morphological changes in the prostate epithelium until the age of over 18 month. Together with the previous in vitro study (Kaulfuss et al., 2008) , these observations show that overexpression of LPXN itself is not sufficient to initiate hyperproliferation or transformation of prostate epithelial cells.
To study the role of LPXN on the progression of an existent tumour, the TRAMP mouse model was used to generate double transgenic LPXN/TRAMP mice. TRAMP mice develop spontaneous PCa that resemble the human course of the disease in morphology and development (Greenberg et al., 1995) . Applying two independent LPXN/TRAMP mouse lines, we could show for the first time that LPXN directly enhances the progression and metastasis of prostate cancer in vivo (Figures 1 and 2) , whereas the onset of prostate lesions remained unaffected. These results are consistent with the data obtained from TAT-LPXN transduction studies in PCa cell lines presented here and from earlier studies, which show a higher migration and invasion rate as compared with control cells (Gupta et al., 2003; Sahu et al., 2007) . In addition, primary cells isolated from both double transgenic LPXN/TRAMP and single transgenic TRAMP prostate tumours, respectively, support these observations in vitro. A clearly elevated migratory and invasive behaviour of LPXN/TRAMP PCa cells in comparison with TRAMP PCa cells could be observed (Figure 3) . Multidomain adaptor proteins, such as LPXN, can directly interact with integrins, cytoskeletal proteins, protein kinases or phosphatases and therefore enable the tumour cell's response to changes in the external microenvironment. Reasonably, paxillin was found to be a key molecule in tumour growth and metastasis in lung cancer (Jagadeeswaran et al., 2008) . Paxillin was found to interact with the pro-migratory integrin a4, which is essential for the regulation of motility, as disruption of paxillin binding leads to increased cell spreading and decreased cell migration (Deakin et al., 2009) . LPXN was also found to interact with integrin a4 (Liu et al., 2002) , which is one receptor subunit for the exracellular matrix molecule fibronectin. Therefore, it is not surprising that LPXN has the highest effect on migration and invasion in prostate cancer cells plated on fibronectin (Supplementary Figure 3) . But the detailed mechanisms of their interactions have still to be determined.
With regard to the putative role of LPXN as an adaptor protein at focal adhesion sites, integrin and adhesion-mediated pathways were analysed to identify the mechanisms behind the observed LPXN-induced migration/invasion. We could show that the expression of p120CTN, an Src kinase substrate, is upregulated in PCa cells with a decreased LPXN expression. This deregulation of p120CTN expression was confirmed in our murine model, showing a more pronounced decline in p120CTN expression in LPXN/TRAMP tumours than in the control tumours. On the basis of these facts, we suggest that a direct negative correlation exists between the expression level of LPXN and the expression of p120CTN. More important, the migratory and invasive behaviour of PCa cells with knockdown of LPXN is downregulated, whereas it is upregulated in PCa cells with knockdown of p120CTN. Knockdown of both LPXN and p120CTN reversed these effects (Figure 7) , showing that LPXN-mediated migration and invasion is clearly dependent on p120CTN.
p120CTN is known to function in different ways to regulate cell adhesion. These include the dynamic regulation of the actin cytoskeleton (Anastasiadis, 2006) , the transport of cadherins to the membrane and the stability of cadherins at the membrane (Reynolds and Carnahan, 2004) . Loss of p120CTN expression results in destablization of cadherins at the cell membrane and subsequently in deprivation of cell-cell adhesion, which is a common event during tumour progression (Hatzfeld, 2005; Kallakury et al., 2001a, b) . In this study we could show for the first time that this observation is directly linked to the overexpression of LPXN in PCa. How LPXN influences p120CTN expression is currently under thorough investigation. In recent reports an important role for paxillin family members in interaction and activation of a series of transcription factors was established (Fujimoto et al., 1999; Yang et al., 2000; Kasai et al., 2003; Shibanuma et al., 2003 Shibanuma et al., , 2004 Wang et al., 2005 Wang et al., , 2008 . Hence, we propose that there could be a direct regulation of p120CTN expression by LPXN itself together with other unknown factors. It is worth noting that the promoter region of p120CTN contains putative steroid receptor-binding sites. Among others, destablization of the catenin-cadherin complex is connected with a release of the transcription factor b-catenin from the adhesion contacts and its translocation into the nucleus (Perez-Moreno and Fuchs, 2006) . b-catenin has been implicated as an integral component of the Wnt signalling pathway, being involved in cell proliferation, migration and adhesion (Fuchs et al., 2005) . Expression, stability and localization of b-catenin are tightly regulated by a number of proteins in response to cellular signals. In this study, we could show in the PCa cell line PC-3, that b-catenin translocates to the nucleus after knockdown of p120CTN expression. More important, b-catenin was present mainly at the cell membrane after downregulated LPXN expression, presumably due to the higher expression level of p120CTN (Figure 8 ). This observation is consistent with previous results obtained in hepatoma cells, which showed a decrease of b-catenin nuclear accumulation on overexpression of p120CTN (Nong et al., 2006) .
An evidence for the teamwork of LPXN, p120CTN and b-catenin in the progression of prostate cancer should be obtained by expression analysis of b-catenin target genes. As LPXN function is not linked to proliferation of PCa cells (Kaulfuss et al., 2008) , we focused on b-catenin target genes highly connected to invasion and migration of tumour cells, for example, MMPs. MMPs are necessary to create a microenvironment supporting the initiation and maintenance of growth of tumours and metastases (Chambers and Matrisian 1997; Gupta and Massague´, 2006; Bidard et al., 2008; Gimona et al., 2008) . In this study, the expression of MMP-7 directly correlated with the expression of LPXN in human PCa cell lines (Figure 8 ). MMP-7 is overexpressed in 80% of human colorectal cancers and is known to be an important factor for early tumour growth, with a potential function also for invasion and metastasis (Brabletz et al., 1999) . Therefore, we hypothesize that the upregulation of MMP-7, as a result of p120CTN deregulation and b-catenin nuclear accumulation, could be one explanation for the elevated migratory and invasive behaviour of LPXN overexpressing PCa cells.
In conclusion, we could confirm a direct involvement of LPXN overexpression on the aggressiveness of PCa cells in the LPXN/TRAMP mouse model. The mechanisms behind the observed remarkable increase of cell invasion and migration seem to be associated with concurrent downregulation of p120CTN, and followed by destablization of the catenin-cadherin complex. Therefore, LPXN could act as a putative marker for highly aggressive PCa, and additional research is required to fully elucidate the exact mechanisms of LPXN-mediated PCa progression.
Materials and methods
Generation of transgenic LPXN and double transgenic LPXN/TRAMP mice TRAMP mice were purchased from the Jackson Laboratory, Bar Harbor, ME, USA. Double heterozygous transgenic LPXN/TRAMP mice were generated by breeding heterozygous TRAMP [C57Bl/6] females with homozygous LPXN [FVB] males (see Supplementary materials and methods). To avoid a phenotypical shift due to background mixture, only the F1 generation of single and double transgenic mice was used for analyses.
Isolation of mouse tail DNA was accomplished using DirectPCR Lysis Reagent according to the supplier's instructions (Peqlab, Erlangen, Germany). The sequences of the synthetic oligonucleotides used for genotyping were as follows: rPB-423-fw: 5 0 -CTCTGCACCTTGTCAGTGA-GGTCCAG-3 0 and SV40 Tag primer rev: 5 0 -CTCCTTTCAAG-ACCTAG AAGGTCCA-3 0 , and LPXN LD-1 primer rev: 5 0 -GAAGGT GGTGGTGATTCCTTTGGCTC-3 0 .
Histology and immunohistochemistry
Double heterozygous LPXN/TRAMP [C57Bl/6 Â FVB] F1 transgenic males were analysed at 6, 10, 14, 18, 22, 26 and 30 weeks of age, respectively. The genitourinary tracts were excised, weighted and together with the lymph nodes, lung, liver, kidney and spleen were fixed in formalin. Haematoxylineosin-stained tissue sections were analysed by a pathologist, and the prostatic lesions were classified into prostate intraepithelial neoplasia (PIN), well-differentiated carcinoma (WDC) and poorly differentiated carcinoma (PDC) complied with the most severe phenotype. Immunohistochemical analyses of prostate tissue sections were carried out as described previously (Kaulfuss et al., 2008) . The mouse monoclonal anti-LPXN (clone 283 G) antibody was kindly provided by ICOS Corp. (Bothell, WA, USA) and applied at a concentration of 3.5 mg/ml. The mouse monoclonal anti-p120 Catenin (clone 98) antibody was purchased from BD Biosciences (San Jose, CA, USA).
Cell culture and transient transfection LNCaP, PC-3 and DU 145 cells were grown in RPMI 1640 medium (PAN-System, Nuremberg, Germany) containing 10% fetal calf serum and 1.2% penicillin/streptomycine. Transient transfection experiments were carried out using FuGene HD (Roche, Mannheim, Germany) according to the manufacturer's instructions. Detailed plasmid description is available in the Supplementary materials and methods.
Mouse prostatic primary cell culture Mouse PCa were harvested from LPXN/TRAMP and TRAMP mice, respectively, and minced with a razor blade under sterile conditions. After washing the tissue with HEPESbuffered saline, a collagenase treatment (1 mg/ml, Sigma, Taufkirchen, Germany) in Medium 199 at 37 1C for 2 h was carried out. The pelleted tissue was resuspended in Medium 199 containing 0.04% DNAse I (Sigma), transferred onto a Biocoll gradient (Biochrom AG, Berlin, Germany) and centrifuged at 2000 r.p.m. for 20 min. The middle fraction was diluted in 50 ml Medium 199. The final cell pellet was resuspended in culture medium (advanced Dulbecco's modified Eagle's medium, Invitrogen, Karlsruhe, Germany) supplemented with 10% fetal calf serum, 8% NuSerum (BD Biosciences), Gentamycine (80 mg/ml, Sigma), Glutamine (2 mM, Invitrogen) and dihydrotestosterone (100 nM, Sigma). The cell suspension was plated onto culture dishes coated with a thin layer of polymerized rat tail collagene.
Western blot analysis
Western blot analysis was carried out as described previously (Kaulfuss et al., 2008) . Proteins of organs were isolated using lysis buffer containing 1 mM EDTA, 1% Triton X-100 and 150 mM HEPES. The following mouse monoclonal antibodies were applied: anti-leupaxin 283 G, anti-p120CTN clone 98, anti-SV40 clone 101 (both BD Biosciences), anti-a-tubulin (Sigma), anti-cmyc (Millipore, Billerica, MA, USA) and rabbit anti-mouse IgG-HRP (Dianova, Hamburg, Germany).
RNA interference
Transfection of PC-3 and DU 145 cells was accomplished as described previously (Kaulfuss et al., 2008) . Additional siRNA duplexes were used: p120CTN-1 sense: 5 0 -GGCUAGAGGAU GACCAGCGUAGUAU-3 0 , p120CTN-1 antisense: 5 0 -AUAC UACGCU-GGUCAUCCUCUAGCC-3 0 , p120CTN-2 sense: 5 0 -GCAG-CUCCCAAUGUUGCCAACAAUA-3 0 p120CTN-2 antisense: 5 0 -UAUUGUUGGCAAC-AUUGGGAGCUGC-3 0 , p120CTN-3 sense: 5 0 -CCCAGGAUCACAGUCACCUUCUA UA-3 0 , p120CTN-3 antisense: 5 0 -UAUAGAAGGUGACUGU GAUCCUGGG-3 0 (stealth siRNA, Invitrogen). Control cells were transfected with siRNA duplex oligonucleotides against the firefly luciferase gene (Grzmil et al., 2003) . After 72 h transfection, cells were collected and used in the subsequent experiments.
Real-time reverse transcription-PCR analysis
Real-time reverse transcription-PCR analysis was carried out as described previously (Kaulfuss et al., 2008) . mRNA expression was normalized to mRNA expression of the housekeeping genes TBP (TATA box binding protein) and PBGD (porphobilinogen deaminase) to compensate for different sample capacities. Primers used for quantitative real-time-PCR were as follows: LPXN-fw 5 0 -ACGCTCCAC CCTTCAGGACA-3 0 ; LPXN-rev 5 0 -GACATTGAGCTCC TGGATATTGG-3 0 ; p120CTN-fw 5 0 -TGGACGTGACCAG GATAACAAGAT-3 0 ; p120CTN-rev 5 0 -GGCGTGGCTTAC AGTCTTCATTAG-3 0 ; MMP-7-Q1-fw 5 0 -CCGCGTCATAG AAATAATGCAGAA-3 0 ; MMP-7-Q1-rev 5 0 -GATGTCAGC AGTTCCCCATACAAC-3 0 ; hMMP-7-Q2-fw 5 0 -CCGCGTC ATAGAAATAATGCAGAA-3 0 ; hMMP-7-Q2-rev 5 0 -GATG TCAGCAGTTCCCCATACAAC-3 0 ; PBGD-fw 5 0 -GCAATG CGGCTGCAACGGCGGAAG-3 0 , PBGD-rev 5 0 -CCTGTGG TGGACATAGCAATGATT-3 0 ; TBP-fw 5 0 -AGCCTGCCAC CTTACGCTCAG-3 0 ; TBP-rev, 5 0 -TGCTGCCTTTGTTGCT CTTCCA-3 0 .
Scratch and matrigel invasion assays
In vitro cell migration of cells was determined as described previously (Kaulfuss et al., 2008) . Briefly, siRNA-transfected PCa or untransfected primary PCa cells were plated in 24-well plates at a density of 6 Â 10 4 cells/well. After 24 h, the scratch was applied and the cells were photographed under an inverted microscope (Olympus IX81; Olympus, Hamburg, Germany). In vitro cell invasion of PC-3 and DU 145 cells was determined in BioCoat Matrigel Invasion Chambers or BioCoat cell culture inserts precoated with fibronectin, collagen I and IV, laminin (BD Biosciences) as described previously (Kaulfuss et al., 2008) .
Immunocytochemistry
Small interfering RNA-transfected PCa or untransfected primary PCa cells were cultured for 72 h under normal culture conditions on culture slides. The cells were then fixed and treated as described previously (Kaulfuss et al., 2008) . The following mouse monoclonal antibodies were used: anti-bcatenin, anti-p120CTN clone 98, anti-SV40 clone 101 (all BD Biosciences) and sheep anti-mouse IgG-Cy3 (Sigma). Fluorescein isothiocyanate conjugated Phalloidin (Sigma) was used to stain F-actin. All images were captured with the confocal laser scanning microscope FluoView1000 (Olympus).
Transduction of TAT fusion proteins
The full-length cDNA for human LPXN was cloned in frame into the bacterial expression vector pET28-TAT-EGFP-Strep to produce a TAT fusion protein (TAT-LPXN). The vector pET28-TAT-EGFP-Strep contains the protein transduction domain flanked by glycine residues, a polylinker and the cDNA of EGFP linked to a Strep-Tag. The empty vector was used as a control (TAT-EGFP). The purification protocol was adapted from the manufacturer's procedure using Strep-Tactin columns (IBA, Go¨ttingen, Germany). For transduction, the TAT fusion proteins were added to cells in a final concentration of 1 mM, and the efficient absorption was monitored after 24 h.
